Media stories, social media posts and the U.S. Centers for Disease Control and Prevention have asserted that selective ...
PsyPost on MSN
Luvesilocin: This new psychedelic drug could change how we treat postpartum depression
About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a ...
In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...
WISN 12 News on MSN
Wisconsin man finds hope after battle with depression using controversial ketamine treatment
Wisconsin Man Finds Hope After Decades of Depression With Ketamine Treatment ...
Compass Pathways (NASDAQ:CMPS) said new 26-week data from its Phase 3 COMP006 trial further support the durability and safety profile of COMP360, its investigational psilocybin therapy for ...
Irish Examiner on MSN
Majella O’Donnell: It's time talk about mental health openly
Majella O’Donnell is not afraid to speak out about her health challenges. After sharing her breast cancer journey in 2013, ...
You probably already take it.
Adults with major depressive disorder experienced statistically significant and clinically meaningful improvements with a ...
All across California, unhoused people are suffering at alarming rates from less obvious but potentially enervating mental ...
When a global technology company was looking for a way to manage its narrative in the market, its CMO didn't start with a ...
Scott used to have her therapy sessions with Anthony Villanueva, a clinician with One Community Health, on a park bench ...
"Ozempic personality" is a social media term, not a medical diagnosis Experts link it to changes in brain dopamine and reward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results